These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective. White GC; Greenwood R; Escobar M; Frelinger JA Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862 [TBL] [Abstract][Full Text] [Related]
8. Summary report of the First International Conference on inhibitors in haemophilia A. Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354 [No Abstract] [Full Text] [Related]
9. Haemophilia A and inhibitors: advances in prevention and ITI treatment optimization. Kruse-Jarres R Haemophilia; 2014 Sep; 20 Suppl 6():1. PubMed ID: 24975699 [No Abstract] [Full Text] [Related]
10. Tolerance and intolerance to factor VIII: a clinical perspective. Briƫt E Adv Exp Med Biol; 1995; 386():193-9. PubMed ID: 8851028 [No Abstract] [Full Text] [Related]
11. Immune tolerance to Factor VIII: the international registry data. Mariani G; Hilgartner M; Thompson AR; Tusell J; Manco-Johnson M; Ghirardini A; Bellocco R; Brackmann HH Adv Exp Med Biol; 1995; 386():201-8. PubMed ID: 8851029 [No Abstract] [Full Text] [Related]